Brief Introduction
Nanjing Haijing Pharmaceutical Co., Ltd. is located in the core area of Jiangbei New District, a state-level new district in Nanjing city of China. Haijing Pharmaceutical is a national high-tech enterprise dedicated to research, development, production, and sales of innovative drugs. The company occupies an area of more than 200 acres, including modernized workshops and office buildings over 35000 m2. The company occupies a R&D center area over 4000 m2, which is equipped with more than 200 sets of precision instruments and apparatus. The company has more than 500 employees, including a group of managerial staff with rich experiences in research and production.
Honors
Haijing Pharmaceutical has been awarded 8 national and provincial honors, such as the National High-Tech Enterprises and the National High-Tech Small and Medium-sized Enterprises. The R&D center of the company has successively won honorary titles such as Guangdong New Drug R&D Engineering Technology Research Center and the Top 20 Chinese Pharmaceutical R&D Companies. Haijing Pharmaceutical has also been successively awarded research grants such as the Technology Innovation Fund for Small and medium-sized Enterprises, the Guangzhou Industry-University-Research Collaborative Innovation Major Project, and the Guangzhou Foreign Cooperation Project.
Products
Haijing Pharmaceutical occupies 9 GMP certified production lines with 9 types of dosage forms. 33 preparation products have been approved by NMPA so far. Haijing Pharmaceutical has also been authorized 17 invention patents, 8 appearance patents, and 28 trademarks.
Sales
The sales of Haijing Pharmaceutical had increased to 0.38 billion yuan in 2021 from 0.22 billion yuan in 2020, which might increase to 0.80 billion yuan and the net profit will increase to 0.12 billion in 2022. Benefit from the strongly growth, the estimated sales of the company are anticipated to increase to 10 billion yuan in 2030.
Website: https://www.njhjyy.com
Address: No. 18, Xinke Sanlu, Jiangbei new area, Nanjing, Jiangsu, China
Professor Wen-Cai Ye is vice president of Jinan University (Guangzhou, China). He received his B.S. at the China Pharmaceutical University in 1983 and PhD at the Hong Kong University of Science & Technology in 2001. Prof. Ye is the recipient of Changjiang Scholar Distinguished Professor, the National Science Foundation for Distinguished Young Scholars, the National Candidate of the New Century Talents Project, and the Nanyue Hundred Outstanding Scholar of Guangdong Province.
Prof. Ye’s research interests focus on the discovery of natural bioactive molecules and the development of innovative drugs, and a number of innovative achievements in these fields have been reached. Prof. Ye had published over 520 peer-reviewed research papers in SCI journals, such as JACS, J Clin Invest, Angew Chem Int Ed, Hepatology, Mol Psychiatry, J Extracell Vesicels, STTT et al. Prof. Ye’s works have been cited for more than 14000 times so far, and he has been selected successively as the Elsevier Chinese Highly Cited Researcher. Prof. Ye has been authorized nine international patents and over 50 Chinese patents, 20 of which had been industrialized. Prof. Ye had developed several new drug candidates, and two of them had been finished the phase III clinical trials. Prof. Ye had also established and improved a series of quality standards for TCM and natural medicines, among which 13 ones have been incorporated in the Pharmacopoeia of the People’s Republic of China. Prof. Ye’s research achievements had improved the re-developments of TCM injections such as Xiyanping and Shenqi Fuzheng, which had brought significant economic and social benefits.
Prof. Ye has been awarded the National Competition Award for Innovation Winner (2020), the second-class prize of National Sciences and Technology Progress Award (2017), the first-class prize of Guangdong Sciences and Technology Awards (2013, 2016 and 2020), the Excellent Award of China Patent (2012), and the first-class prize of China Innovative Achievement Awards of China Industry-University-Research Institute collaboration (2016 and 2019). In addition, Prof. Ye is an award winner of the China Pharmaceutical Science Development Award, Guangdong Ding Ying Scientific & Technology Award, the State Council Special Allowance, the National Model Teacher, and the National Outstanding Scientific and Technological Workers Award.
